Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Saunders

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Physical Biology|February 9, 2011
Adipose progenitor cells increase fibronectin matrix strain and unfolding in breast tumorsE M Chandler, M P Saunders, C J Yoon, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 11, 2004
Anal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppressionV S Khoo, M P Saunders, R Gowda, et al.
Epidemiology and Infection|September 24, 2010
Optical genetic mapping defines regions of chromosomal variation in serovars of S. enterica subsp. enterica of concern for human and animal healthM P Saunders, G Wu, M Abuoun, et al.
British Journal of Cancer|February 22, 2000
NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell lineM P Saunders, A V Patterson, E C Chinje, et al.
Anti-Cancer Drug Design|October 2, 1998
Enzymology of tirapazamine metabolism: a reviewA V Patterson, M P Saunders, E C Chinje, et al.
Journal of the Royal Society of Medicine|March 5, 2004
Waiting times for treatment of rectal cancer in North West EnglandS E Duff, C Wood, V McCredie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
Hypersensitivity reactions to cisplatin and carboplatin--a report on six casesM P Saunders, C P Denton, M E O'Brien, et al.
Ebiomedicine|February 9, 2019
Biomarker concordance between primary colorectal cancer and its metastasesD S Bhullar, J Barriuso, S Mullamitha, et al.
British Journal of Cancer|December 10, 1999
Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?E C Chinje, A V Patterson, M P Saunders, et al.
British Journal of Cancer|September 22, 2012
Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancerA Greystoke, E Dean, M P Saunders, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Physical Biology|February 9, 2011
Adipose progenitor cells increase fibronectin matrix strain and unfolding in breast tumorsE M Chandler, M P Saunders, C J Yoon, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 11, 2004
Anal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppressionV S Khoo, M P Saunders, R Gowda, et al.
Epidemiology and Infection|September 24, 2010
Optical genetic mapping defines regions of chromosomal variation in serovars of S. enterica subsp. enterica of concern for human and animal healthM P Saunders, G Wu, M Abuoun, et al.
British Journal of Cancer|February 22, 2000
NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell lineM P Saunders, A V Patterson, E C Chinje, et al.
Anti-Cancer Drug Design|October 2, 1998
Enzymology of tirapazamine metabolism: a reviewA V Patterson, M P Saunders, E C Chinje, et al.
Journal of the Royal Society of Medicine|March 5, 2004
Waiting times for treatment of rectal cancer in North West EnglandS E Duff, C Wood, V McCredie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
Hypersensitivity reactions to cisplatin and carboplatin--a report on six casesM P Saunders, C P Denton, M E O'Brien, et al.
Ebiomedicine|February 9, 2019
Biomarker concordance between primary colorectal cancer and its metastasesD S Bhullar, J Barriuso, S Mullamitha, et al.
British Journal of Cancer|December 10, 1999
Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?E C Chinje, A V Patterson, M P Saunders, et al.
British Journal of Cancer|September 22, 2012
Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancerA Greystoke, E Dean, M P Saunders, et al.
Pageof 6